Hiroshi Maegawa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Journal of diabetes investigation

Diabetology international

Nutrients

Diabetes, obesity & metabolism

Shiga University of Medical Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shiga University of Medical Science Jan 01 2010

Japan

Professor :: Department of Medicine

Publications

Yohei Hayashi, Yukiko Tando, Yumi Ito-Matsuoka, Kaho Ikuta, Asuka Takehara, Katsutaro Morino, Hiroshi Maegawa, Yasuhisa Matsui
Nutritional and metabolic control of germ cell fate through O-GlcNAc regulation. EMBO reports (2023)
Ken-Ichi Tsuchida, Shinji Taneda, Isao Yokota, Kazufumi Okada, Yoshio Kurihara, Hiroki Yokoyama, Masahiro Iwamoto, Katsuya Yamazaki, Yasushi Ishigaki, Naoki Manda, Hiroshi Maegawa, null null
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67). Journal of diabetes investigation 13 (11) (2022)
Shinji Kume, Hiroshi Maegawa
A new era of diabetic kidney disease treatment with sodium-glucose cotransporter-2 inhibitors. Journal of diabetes investigation 13 (5) (2022)
Takashi Kadowaki, Hiroshi Maegawa, Hirotaka Watada, Daisuke Yabe, Koichi Node, Toyoaki Murohara, Jun Wada
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan. Diabetes, obesity & metabolism 24 (12) (2022)
Shinichiro Shirabe, Katsuya Yamazaki, Mariko Oishi, Keiko Arai, Noriharu Yagi, Manaka Sato, Masakazu Takeuchi, Takahito Kai, Hiroshi Maegawa
Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70). Journal of diabetes investigation (2022)
Phap Tran Ngoc Hoang, Aya Kadota, Yuichiro Yano, Akiko Harada, Takehito Hayakawa, Shohei Okamoto, Naoko Miyagawa, Keiko Kondo, Nagako Okukda, Yoshiuni Kita, Akira Okayama, Yukihiro Fujita, Hiroshi Maegawa, Katsuyuki Miura, Tomonori Okamura, Hirotsugu Ueshima, null null
Effect of diabetes and prediabetes on the development of disability and mortality among middle-aged Japanese adults: A 22-year follow up of NIPPON DATA90. Journal of diabetes investigation 13 (11) (2022)
Kazuya Fujihara, Yasuhiro Matsubayashi, Mayuko Harada Yamada, Masahiko Yamamoto, Toshihiro Iizuka, Kosuke Miyamura, Yoshinori Hasegawa, Hiroshi Maegawa, Satoru Kodama, Tatsuya Yamazaki, Hirohito Sone
Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study. JMIR medical informatics 9 (1) (2021)
Koichi Kawai, Jun-Ichi Eiki, Azuma Kanatsuka, Shinobu Motohashi, Akira Wakana, Ai Hayashi, Kristy Iglay, Katsuya Yamazaki, Shigeru Tokita, Hiroshi Maegawa, null null
Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60). Diabetology international 13 (1) (2021)
Yasunaga Takeda, Kazuya Fujihara, Rina Nedachi, Izumi Ikeda, Sakiko Yoshizawa Morikawa, Mariko Hatta, Chika Horikawa, Mitsutoshi Kato, Noriko Kato, Hiroki Yokoyama, Yoshio Kurihara, Kazuhiro Miyazawa, Hiroshi Maegawa, Hirohito Sone
Comparing Associations of Dietary Energy Density and Energy Intake, Macronutrients with Obesity in Patients with Type 2 Diabetes (JDDM 63). Nutrients 13 (9) (2021)
Noriharu Yagi, Ichiro Komiya, Keiko Arai, Mariko Oishi, Yoshihide Fukumoto, Shinichirou Shirabe, Hiroki Yokoyama, Katsuya Yamazaki, Hidekatsu Sugimoto, Hiroshi Maegawa, null null
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61). Journal of diabetes investigation (2021)
Azuma Kanatsuka, Yasunori Sato, Yoichiro Higashi, Yoshimasa Goto, Koichi Kawai, Hiroshi Maegawa, null null
Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59). Journal of diabetes investigation 12 (11) (2021)
Hiroshi Maegawa, Kazuyuki Tobe, Ichiro Nakamura, Satoshi Uno
Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Diabetology international 12 (4) (2021)
Hiroshi Maegawa, Yasushi Ishigaki, Jakob Langer, Ai Saotome-Nakamura, Marc Andersen, null null
Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53). Journal of diabetes investigation 12 (3) (2020)
Atsunori Kashiwagi, Shin-Ichi Araki, Hiroshi Maegawa
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients. Journal of diabetes investigation 12 (1) (2020)
Katsutaro Morino, Hiroshi Maegawa
Role of O-linked N-acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications. Journal of diabetes investigation 12 (2) (2020)

Hiroshi Maegawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroshi Maegawa